July 03, 2024CorporateNICE PUBLISHES NEW GUIDANCE SUPPORTING THE USE OF HOLMIUM-166 SELECTIVE INTERNAL RADIATION THERAPY FOR UNRESECTABLE ADVANCED HEPATOCELLULAR CARCINOMA
June 26, 2024CorporateMicroVention Announces the Next Evolution in Stent Innovation: MicroVention’s LVIS™ EVO™ Intraluminal Support Device Now Available in the United StatesMicroVention Continues to Lead the Way in Innovation for both Ischemic and Hemorrhagic Stroke Treatment and Prevention
February 24, 2021 Terumo Signs a Definitive Agreement to Acquire All Assets of Health Outcomes Sciences, Inc. Transaction furthers Terumo’s efforts to improve patient outcomes and decrease healthcare costs through personalized predictive analytics and clinical decision support at the point of care February 04, 2021 Terumo Revises its Full-Year Financial Guidance for FY2020 (PDF 223.72 KB) Pagination Previous page ‹ Page1 Current page2 Next page ›
February 24, 2021 Terumo Signs a Definitive Agreement to Acquire All Assets of Health Outcomes Sciences, Inc. Transaction furthers Terumo’s efforts to improve patient outcomes and decrease healthcare costs through personalized predictive analytics and clinical decision support at the point of care